GRANT ANGUS (EVP, Business Development) sold 31.5% of their position (4.07K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $70.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2024ACC: 0000950170-24-096182
Officer· EVP, Business Development
Since Aug 2023
-4.07K
Net shares
Net seller
$70.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
12.91K acquired · 16.98K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+12.91K
Price / share
—
Trade value
—
% of position
New position
8/9/2024
0.00→12.91K
Ordinary Shares
Direct
Shares
−4.07K
Price / share
$17.28
Trade value
$70.24K
% of position
31.5%
8/9/2024
12.91K→8.85K
Total
Net shares
+8.85K
Net value
-$70.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/9/2024 | M · Option Exercise | +12.91K | — | — | New position | 0.00 | 12.91K |
| Ordinary Shares Direct | 8/9/2024 | S · Sale | −4.07K | $17.28 | $70.24K | 31.5% | 12.91K | 8.85K |
| Total | +8.85K | -$70.24K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
12.91K shares
Shares
−12.91K
Strike price
Held after
38.74K
Exercisable
—
8/9/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares12.91K shares | 8/9/2024 | M · Option Exercise | −12.91K | — | 38.74K |